Lake Street Advisors Group LLC raised its position in Align Technology, Inc. (NASDAQ:ALGN – Free Report) by 5.6% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,042 shares of the medical equipment provider’s stock after purchasing an additional 55 shares during the quarter. Lake Street Advisors Group LLC’s holdings in Align Technology were worth $265,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also modified their holdings of the company. Vanguard Group Inc. raised its holdings in Align Technology by 0.3% in the first quarter. Vanguard Group Inc. now owns 8,375,147 shares of the medical equipment provider’s stock valued at $2,746,378,000 after buying an additional 25,362 shares during the period. Bank of New York Mellon Corp raised its stake in shares of Align Technology by 1.4% in the 2nd quarter. Bank of New York Mellon Corp now owns 1,148,282 shares of the medical equipment provider’s stock valued at $277,230,000 after acquiring an additional 15,540 shares during the period. Ninety One UK Ltd raised its stake in shares of Align Technology by 1.0% in the 2nd quarter. Ninety One UK Ltd now owns 1,147,124 shares of the medical equipment provider’s stock valued at $276,950,000 after acquiring an additional 10,919 shares during the period. Bares Capital Management Inc. lifted its holdings in shares of Align Technology by 44.4% during the 1st quarter. Bares Capital Management Inc. now owns 819,930 shares of the medical equipment provider’s stock valued at $268,871,000 after acquiring an additional 252,220 shares in the last quarter. Finally, Disciplined Growth Investors Inc. MN boosted its position in Align Technology by 0.5% during the 2nd quarter. Disciplined Growth Investors Inc. MN now owns 707,542 shares of the medical equipment provider’s stock worth $170,822,000 after purchasing an additional 3,600 shares during the period. 88.43% of the stock is owned by institutional investors and hedge funds.
Insiders Place Their Bets
In other Align Technology news, Director C Raymond Larkin, Jr. purchased 6,500 shares of Align Technology stock in a transaction dated Thursday, August 15th. The shares were bought at an average cost of $235.33 per share, for a total transaction of $1,529,645.00. Following the transaction, the director now owns 28,247 shares in the company, valued at $6,647,366.51. This represents a 0.00 % increase in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 0.62% of the stock is currently owned by corporate insiders.
Wall Street Analysts Forecast Growth
View Our Latest Stock Report on ALGN
Align Technology Stock Performance
Shares of Align Technology stock opened at $219.30 on Friday. Align Technology, Inc. has a 1 year low of $176.34 and a 1 year high of $335.40. The firm’s 50-day simple moving average is $233.41 and its 200-day simple moving average is $250.02. The firm has a market cap of $16.51 billion, a PE ratio of 36.13, a price-to-earnings-growth ratio of 5.33 and a beta of 1.64.
Align Technology (NASDAQ:ALGN – Get Free Report) last announced its quarterly earnings data on Wednesday, October 23rd. The medical equipment provider reported $2.35 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.31 by $0.04. Align Technology had a return on equity of 14.07% and a net margin of 11.34%. The firm had revenue of $977.87 million for the quarter, compared to analysts’ expectations of $990.05 million. During the same quarter in the prior year, the firm posted $1.62 earnings per share. Align Technology’s revenue for the quarter was up 1.8% compared to the same quarter last year. On average, equities analysts predict that Align Technology, Inc. will post 7.61 earnings per share for the current year.
Align Technology Company Profile
Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.
Further Reading
- Five stocks we like better than Align Technology
- When to Sell a Stock for Profit or Loss
- Lam Research Proves Analysts Wrong with a Strong Earnings Report
- Using the MarketBeat Dividend Tax Calculator
- PureCycle: Up 250% in 2024 – Is This Materials Stock Still a Buy?
- The Basics of Support and Resistance
- MarketBeat Week in Review – 10/21- 10/25
Receive News & Ratings for Align Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Align Technology and related companies with MarketBeat.com's FREE daily email newsletter.